Leiomyosarcoma of the splenic vein  by Gage, Mark J. et al.
Leiomyosarcoma of the splenic vein
Mark J. Gage, MD,a Elliot Newman, MD,a Thomas S. Maldonado, MD,b and
Cristina H. Hajdu, MD,c New York, NY
Leiomyosarcomas are smooth muscle-derived tumors generally found intra-abdominally in the retoperitoneum, mesen-
tery, or omentum. Only approximately 5% of these tumors originate from vessel wall smooth muscle. Those derived from
the splenic vein are exceedingly rare, with only one previously published case in the literature. We present a second case
of leiomyosarcoma of the splenic vein in a 58-year-old woman with 2 months of epigastric pain. A distal pancreatectomy
was performed to include the tumor found centered in the splenic vein at the splenic and portal vein confluence and
growing into the pancreas in the body on the posterior aspect. A saphenous vein patch was used for reconstruction.
(J Vasc Surg 2012;55:1485-7.)
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fLeiomyosarcomas are tumors derived from smooth
muscle. They generally occur intra-abdominally in the re-
toperitoneum, mesentery, or omentum (40%-45%), in sub-
cutaneous or deep soft tissue of the limbs (20%-30%), from
the arrecter muscle of the skin (15%-20%), and from vessel
wall (5%).1 Venous leiomyosarcomas are the most common
vascular tumors. They arise predominately in women in the
inferior vena cava or in large size veins of the lower extrem-
ities. Reports of visceral vein leiomyosarcomas also exist.1
Those derived from the splenic vein are exceedingly rare
with only one previously published case in the literature.2
We present the second case of leiomyosarcoma of the
splenic vein.
CASE REPORT
A 58-year-old white woman presented with 2 months of
epigastric pain. She described the pain as nonradiating burning.
She denied any weight loss, appetite changes, jaundice, fever, or
chills at that time. She further denied history of pancreatitis.
Initial evaluation by gastroenterology included a negative
upper endoscopy. This was followed by a computed tomography
(CT) scan of the abdomen and pelvis with intravenous and oral
contrast, where a soft-tissue lesion approximately 1.9 cm 1.5 cm
was identified on the inferior aspect of the pancreas in association
with a thrombosed splenic vein that was extending into the portal
vein (PV) (Fig 1). The mass was described as a mixed attenuation
involving the splenic vein, extending into the superior mesenteric
and PVs and posterior margin of the pancreas. There was no
evidence of peritoneal implants or distant disease on the scan. She
was referred for a surgical oncology evaluation.
Based on the findings observed on CT imaging, the differen-
tial diagnosis included primary pancreatic cancer, endocrine pan-
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doi:10.1016/j.jvs.2011.09.053reatic neoplasm, or a soft-tissue retroperitoneal tumor. The pos-
ibility that the soft-tissue abnormality could be arising from the
plenic vein vessel wall was also considered. She was advised to
ndergo surgical exploration. Diagnostic laparoscopy did not re-
eal any distant disease, and an open exploration followed.
A midline incision was made. The lesser sac was entered,
xposing the pancreas. The mass was palpable on the inferior
order of the pancreas. The peritoneum was incised with the
umor and the pancreatic body elevated out of the retroperito-
eum. The superior mesenteric artery was not involved, nor was
ny other critical retroperitoneal structures. The inferior pancreatic
order was traced to the superior mesenteric vein (SMV), and a
unnel was created underneath the pancreatic neck to the superior
order of the pancreas over the PV. The pancreatic parenchyma
as free at this level and the pancreas was divided with the endoGI
niversal stapler. The parenchyma was now free of the SMV and
V, allowing for proximal and distal control of the vessels. The
umor thrombus extended to the confluence of the splenic vein
nd PV but was not involving the pancreatic parenchyma. A
enotomy was made and the tumor thrombus removed. Next, the
plenic vein was divided and the defect repaired with a saphenous
ein patch to ensure adequate lumen for the SMV/PV (Fig 2). The
emainder of the distal pancreatectomy and splenectomy were
erformed in standard manner as the mass was easily elevated. The
atient tolerated the procedure without complication.
Grossly, the tumor was nodular in appearance. Final pathology
evealed a primary leiomyosarcoma arising from the smooth mus-
le of the splenic vein, invasive into the body of the pancreas and
eripancreatic adipose tissue. The tumor was measured to be 3.5
m  3.0 cm  3.0 cm. Cellularly, the tumor was composed of
pindle cell fascicles with areas of hypo- and hypercellularity and
esidual pancreatic acini (Fig 3). Tumor nuclei were notably elon-
ated with focal nuclear hyperchromasia and moderate-to-severe
uclear pleomorphism, with up to 13 mitotic figures identified in
0 high-power fields in most mitotically active areas. Tumor cells
ere positive for actin and desmin, confirming smooth muscle
rigin. The histologic margins were free of tumor. The excised
umor thrombus measured 1.9 cm  1.5 cm  1 cm and micro-
copically was consistent with leiomyosarcoma.
The patient’s postoperative course was unremarkable and she
as subsequently discharged on postoperative day 5. She will be
ollowed every 4 months for the first 2 years, every 6 months for
ears 3 to 5, and annually after that with history, physical, and
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May 20121486 Gage et alimaging if she remains asymptomatic. If she becomes symptomatic,
follow-up will be altered as appropriate. Currently, at 15 months
follow-up, she has no evidence of local recurrence or disseminated
disease.
DISCUSSION
Leiomyosarcoma is a rare malignant mesenchymal tu-
mor of smooth muscle origin. They are generally located in
the uterus, retroperitoneum, deep soft tissue, or subcuta-
neous tissue, with only a minority of cases arising from
blood vessels. Those that are vascular in origin represent
only 2% of all leiomyosarcoma cases.3 In a review of 86
vascular cases, venous-derived leiomyosarcomas were five-
fold more frequent than arterial tumors.3 Of those that are
venous in origin, roughly 50% are found in the inferior vena
cava.4 Additionally, most leiomyosarcomas tend to be lo-
Fig 1. Axial view of computed tomography with IV contrast
demonstrating a tumor (indicated by arrow) arising posteriorly to
the pancreas in the region of the splenic vein with partial vein
thrombosis.
Fig 2. Intraoperative photo illustrating the tumor (identified
with forceps) originating from the splenic vein after surgical resec-
tion of the distal pancreas. PV, Portal vein; SMV, superior mesen-
teric vein; SV, splenic vein.cated viscerally, with only one-third found in the lower lxtremities and a select number of cases found in the upper
xtremity.5
With regards to treatment, most soft-tissue sarcomas
ndergo surgical resection for localized primary tumors.
esection offers the only opportunity for complete cure in
he absence of disseminated disease. In addition to tumor
xtent, histologic evaluation for classification and grade is
lso important in guiding treatment. This information can
id in determining the metastatic potential of the sarcoma
nd, furthermore, if any adjuvant treatment is warranted.
adiotherapy has been suggested for high-grade soft-tissue
arcomas located in the extremities and for intermediate-
rade tumors of the limbs with close or positive histologic
argins. Its role in intra-abdominal sarcoma treatment is
ore controversial, and in this patient with intravascular
nvolvement of tumor, the more likely recurrence pattern
ould be distant, not local, and therefore it was not used as
art of her treatment plan. It has also been suggested for
ow-grade sarcomas in the cases of recurrence. Chemother-
py is considered when the goal of therapy is systemic
ontrol; however, sarcoma sensitivity to chemotherapy is
oor, which appears to also hold true for leiomyosarco-
as.6 As a form of adjuvant treatment, chemotherapy does
ot seem to provide an increase in survival. In a meta-
nalysis of soft-tissue sarcomas treated with adjuvant che-
otherapy, no improvement in survival time was ob-
erved.7 Based on these data, it was felt that adjuvant
hemotherapy was not warranted in this case, particularly
fter an R0 resection.
Given the rarity of venous-origin leiomyosarcomas,
here are limited outcome data of this particular subset of
arcomas. In a study of 25 patients with primary inferior
ena cava leiomyosarcomas over a 20-year period, patients
ho underwent complete resection had a 3-year survival
ate of 76% and a 5-year rate of 33%, while those with
ncomplete resection had no survivors after 3 years.8 Simi-
ig 3. Leiomyosarcoma invasive into pancreatic tissue: residual
cini are seen in the upper left side and few islets in the upper right
ide (40 hematoxylin and eosin).ar-sized studies also report poor 5-year survival rates of
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resection. While there is some limited evidence demon-
strating a survival benefit with adjuvant radiation as well as
with combination radiation and chemotherapy therapy in
addition to surgical resection,9 the incorporation of these
treatment modalities is still being debated. In a review of 40
cases of leiomyosarcomas limited to the inferior vena cava,
poor prognostic factors were determined to include those
with incomplete surgical resection and predominantly in-
tralumenal growth, but did not correlate with tumor grade
or tumor size.10
Our report of a leiomyosarcoma derived from the
splenic vein is, to our knowledge, the second published case
of splenic vein leiomyosarcoma in themedical literature and
the first in the English language literature. The previous
report2 describes a man presenting similarly to this case
with epigastric pain but found to have a much larger lesion
on CT than this case, measuring 15 cm  5 cm  6 cm.
Treatment involved a distal pancreatectomy with local
lymph node dissection, and the patient remained disease-
free at 3 years. A more thorough analysis of the radiological
imaging for this case was performed by Niver et al,12
discussing the imaging characteristics observed in splanch-
nic cases of leiomyosarcomas and using this case as an
example.
CONCLUSIONS
It is clear that with only the second reported case of its
kind, leiomyosarcomas of splenic vein origin are rare occur-
rences. Because of this rarity, unique treatment recommen-
dations or outcome data for a splenic vein leiomyosarcoma
cannot be established. General management principles Should follow established guidelines for other vascular leio-
yosarcomas and leiomyosarcomas in general.
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